Early in the progression of Alzheimer's and other neurodegenerative diseases, DNA inside neurons starts showing signs of ...

Few places on the planet have more at stake in AI’s transformation and disruption of life sciences than the Massachusetts ...

BRAIN, an open-source AI scientist deploying three free computational tools to accelerate Alzheimer's drug discovery.

Dr. Car brings more than 30 years of drug discovery experience to lead Bexorg's next phase of clinical translation; Dr. Fenn joins Bexorg to lead business development, asset strategy, and corporate de ...

Sofinnova Partners ("Sofinnova"), a leading European venture capital firm in life sciences, based in Paris, London, and Milan, announced the appointment of David Evans as Partner. A ...

Pharma platform company China Medical System Holdings (CMS) has tapped up existing partner Insilico for a 1.2 billion yuan ...

The latest phase 2 readout for Q32 Bio’s alopecia hopeful received a warm reception from investors, backing up the biotech’s ...

With PAT, pharmaceutical manufacturers achieve real-time process control, enhancing drug quality and accelerating the ...

The Federal Government has expanded financial support for cancer patients through targeted health funds and insurance ...

FDA grant of RMAT designation to Allocetra™ reinforces the potential of this program to deliver a meaningful, disease-modifying impact in age-related primary knee osteoarthritis, where patients face ...

Fulgent Genetics remains a long-term play, supported by a strong balance sheet and disciplined capital allocation. Read more ...

By Fatos Bytyci and Edward McAllister TIRANA, July 11 (Reuters) - A Miami-based businessman wanted in Albania for allegedly ...